192 results on '"Quevedo, João"'
Search Results
2. Effects of paradoxical sleep deprivation on oxidative parameters in the serum and brain of mice submitted to the animal model of hyperglycemia
3. Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report
4. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
5. Potential mechanisms of action of resveratrol in prevention and therapy for mental disorders
6. Biological rhythms are correlated with Na+, K+-ATPase and oxidative stress biomarkers: A translational study on bipolar disorder
7. Folic acid does not have an anti-manic effect but protect the brain against oxidative stress in an animal model of mania induced by ouabain
8. Stress levels, psychological symptoms, and C-reactive protein levels in COVID-19: A cross-sectional study
9. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis
10. Sex differences on the response to antidepressants and psychobiotics following early life stress in rats
11. Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder
12. Contributions of epigenetic inheritance to the predisposition of major psychiatric disorders: Theoretical framework, evidence, and implications
13. Significant reduction in depressive symptoms among patients with moderately-severe to severe depressive symptoms after participation in a therapist-supported, evidence-based mobile health program delivered via a smartphone app
14. Environmental enrichment improves lifelong persistent behavioral and epigenetic changes induced by early-life stress
15. New agents and perspectives in the pharmacological treatment of major depressive disorder
16. Ouabain induces memory impairment and alter the BDNF signaling pathway in an animal model of bipolar disorder: Cognitive and neurochemical alterations in BD model
17. Protein kinase C isoforms as a target for manic-like behaviors and oxidative stress in a dopaminergic animal model of mania
18. Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: A case-control study
19. Accelerated aging in bipolar disorder: A comprehensive review of molecular findings and their clinical implications
20. Neurodevelopmental pathways in bipolar disorder
21. The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder
22. Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?
23. Effects of lithium and valproate on behavioral parameters and neurotrophic factor levels in an animal model of mania induced by paradoxical sleep deprivation
24. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
25. Maternal deprivation increases microglial activation and neuroinflammatory markers in the prefrontal cortex and hippocampus of infant rats
26. Preliminary investigation of peripheral extracellular vesicles’ microRNAs in bipolar disorder
27. Tamoxifen has an anti-manic effect but not protect the brain against oxidative stress in an animal model of mania induced by ouabain
28. Effects of lithium and valproate on ERK/JNK signaling pathway in an animal model of mania induced by amphetamine
29. Moving pharmacoepigenetics tools for depression toward clinical use
30. Determinants for Meaningful Clinical Improvement of Pain and Health-Related Quality of Life After Spinal Cord Stimulation for Chronic Intractable Pain
31. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder
32. Major depression model induced by repeated and intermittent lipopolysaccharide administration: Long-lasting behavioral, neuroimmune and neuroprogressive alterations
33. The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats
34. Author reply to letter to the editor regarding “Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.”
35. ω-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress
36. Intravenous infusion of xenon-containing liposomes generates rapid antidepressant-like effects
37. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes
38. The miRNome of bipolar disorder
39. The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies
40. Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia
41. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
42. The additive effect of aging on sepsis-induced cognitive impairment and neuroinflammation
43. Food addiction: Prevalence, psychopathological correlates and associations with quality of life in a large sample
44. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms
45. The translocator protein (18 kDa) and its role in neuropsychiatric disorders
46. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress
47. The impact of chronic mild stress on long-term depressive behavior in rats which have survived sepsis
48. Mechanism of synergistic action on behavior, oxidative stress and inflammation following co-treatment with ketamine and different antidepressant classes
49. Chapter 12 - Mechanisms of action of vagus nerve stimulation
50. Chapter 28 - Neuroprotection induced by neurotrophic factors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.